Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing...

Area of Science:

• Obstetrics and Gynecology
• Anesthesiology
• Pelvic Surgery

Background:

• Pre-emptive gabapentin is known to reduce postoperative pain after hysterectomy.
• Its efficacy in vaginal hysterectomy combined with pelvic reconstruction, especially at low doses, remains unstudied.

Purpose of the Study:

• To evaluate the effectiveness of pre-emptive low-dose gabapentin in reducing postoperative pain and opioid consumption.
• To assess the impact on sedation and recovery room stay in patients undergoing vaginal hysterectomy with pelvic reconstruction.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted.
• Participants received either gabapentin (600 mg <65 years; 300 mg >65 years) or a placebo.
• Primary outcome: opioid consumption in the first 24 hours; secondary outcomes: sedation, recovery room stay, and pain scores (VAS).

Main Results:

• Twenty-one patients received gabapentin and 26 received a placebo.
• No significant differences were observed between groups in opioid requirements, recovery room stay, or visual analog scale (VAS) scores for pain, anxiety, or nausea.
• Demographic and clinical characteristics were similar between the gabapentin and placebo groups.

Conclusions:

• Pre-emptive administration of low-dose gabapentin did not significantly reduce postoperative pain or opioid requirements.
• The findings suggest that institutional low doses of gabapentin are not effective for pain management in this specific surgical population.